Medicaments
AssigneeGlaxo Group Limited
InventorsJoanne Craig, Derek Leslie Crookes, Stephen John Skittrall
Life of this patent
Estimating the term…
Abstract
The present invention, relates to 3-2-(dimethylamino)ethyl!-N-methyl-1H-methanesulphonamide sulphate salt (2:1) and pharmaceutically acceptable solvates thereof, and to pharmaceutical compositions containing same. The compound is useful in the treatment of conditions associated with cephalic pain, in particular migraine. The pharmaceutical compositions are particularly useful as intranasal formulations.
Claims7
3-2-(dimethylamino)ethyl!-N-methyl-1H-indole-5-methanesulphonamide hemisulphate salt (2:1) or a physiologically acceptable solvate thereof.
A pharmaceutical composition which comprises 3-2-(dimethylamino)ethyl!-N-methyl-1H-indole-5-methanesulphonamide hemisulphate salt (2:1) or a physiologically acceptable solvate thereof as active ingredient together with a pharmaceutically acceptable carrier.
A method of treating a human suffering from or susceptible to cephalic pain which comprises administration of an effective amount of 3-2-(dimethylamino)ethyl!-N-methyl-1H-indole-5-methanesulphonamide hemisulphate salt (2:1) or a physiologically acceptable solvate thereof to the human in need thereof.
Dependencies are inferred from the claim text.